Decibel Therapeutics Insiders
Decibel Therapeutics employs about 68 people. The company is managed by 10 executives with a total tenure of roughly 159 years, averaging almost 15.0 years of service per executive, having 6.8 employees per reported executive. Break down of Decibel Therapeutics' management performance can provide insight into the company performance.
Decibel |
Decibel Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.3265) % which means that it has lost $0.3265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7676) %, meaning that it created substantial loss on money invested by shareholders. Decibel Therapeutics' management efficiency ratios could be used to measure how well Decibel Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Decibel Therapeutics Workforce Comparison
Decibel Therapeutics is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 980. Decibel Therapeutics holds roughly 68.0 in number of employees claiming about 7% of equities under Health Care industry.
Decibel Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Decibel Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Decibel Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Decibel Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kapusta Matthew C over a year ago Disposition of 10000 shares by Kapusta Matthew C of Decibel Therapeutics subject to Rule 16b-3 | ||
Gsk Plc over a year ago Conversion by Gsk Plc of 458487 shares of Decibel Therapeutics | ||
Mclaughlin Kevin F over a year ago Acquisition by Mclaughlin Kevin F of 5000 shares of Decibel Therapeutics subject to Rule 16b-3 | ||
Kapusta Matthew C over a year ago Acquisition by Kapusta Matthew C of 10000 shares of Decibel Therapeutics subject to Rule 16b-3 | ||
Laurence Reid over a year ago Acquisition by Laurence Reid of 195000 shares of Decibel Therapeutics subject to Rule 16b-3 | ||
John Lee over a year ago Acquisition by John Lee of 120000 shares of Decibel Therapeutics subject to Rule 16b-3 |
Decibel Therapeutics Notable Stakeholders
A Decibel Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Decibel Therapeutics often face trade-offs trying to please all of them. Decibel Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Decibel Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Anna MA | Ex Officer | Profile | |
| Gabriel Corfas | CoFounder Board | Profile | |
| James Murphy | Principal CFO | Profile | |
| Charles Liberman | CoFounder Board | Profile | |
| John Lee | Chief Officer | Profile | |
| Joe Burns | VP Discovery | Profile | |
| Elaine Cope | VP Operations | Profile | |
| Ulrich Mller | CoFounder Board | Profile | |
| Laurence Reid | CEO Pres | Profile | |
| Albert Edge | CoFounder Board | Profile |
Decibel Therapeutics Workforce Analysis
Traditionally, organizations such as Decibel Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Decibel Therapeutics within its industry.Decibel Therapeutics Manpower Efficiency
Return on Decibel Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 926.5K | |
| Net Loss Per Executive | 6.3M | |
| Working Capital Per Employee | 1.3M | |
| Working Capital Per Executive | 8.6M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |